Serum Institute of India COVID-19 Vaccine advances to trial for phase-III on 1500 Indian patients

Upon clearance, Oxford vaccine manufactured by Serum Institute will be tested on 1500 patients at 14 locations.

Prime Minister Modi has announced during his Independence Day Speech, “India has three vaccines.” The first by Serum Institute of India, Pune, manufacturing a vaccine developed by Oxford University. The second by Bharat Biotech’s Covaxin, jointly developed with ICMR. The third by Zydus Cadila, called Zycov D.

Serum institute has completed phase II-B3 trails and will commence phase-III trail after clearances. The third phase trail will be tested on 1500 patients at 14 locations. Balram Bhargava, Director general of the Indian Council of Medical Research, said, “The testing will not be random and will only be tested on those who show COVID-19 symptoms.”

Advertisement

The Oxford vaccine is in the most advanced stages of being developed, and is predicted release in the next two months.

Zycov D and Bharat have cleared phase 1 trails on humans. Zydus Cadila says it may be able to launch the vaccine by next year. Researchers continue efforts on releasing COVID vaccines.